Literature DB >> 8164394

Binding of fentanyl and pethidine to muscarinic receptors in rat brain.

O Hustveit1.   

Abstract

Symptoms similar to the central anticholinergic syndrome are often seen after high dose fentanyl anesthesia. Therefore, the binding of fentanyl, alfentanil, pethidine and morphine to opioid and muscarinic receptors was investigated in rat brain homogenate with [3H]naloxone and [3H]QNB as the radioligands, respectively. Both pethidine and fentanyl inhibited [3H]QNB binding with Ki values in the micromolar range. Alfentanil and morphine had no affinity for muscarinic receptors. The ratio of the Ki values for muscarinic receptors versus opioid receptors was 2.5 for pethidine and 88 for fentanyl. It is concluded that binding of fentanyl to muscarinic receptors is likely to occur during high-dose fentanyl anesthesia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164394     DOI: 10.1254/jjp.64.57

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  4 in total

1.  Computational Systems Pharmacology-Target Mapping for Fentanyl-Laced Cocaine Overdose.

Authors:  Jin Cheng; Siyi Wang; Weiwei Lin; Nan Wu; Yuanqiang Wang; Maozi Chen; Xiang-Qun Xie; Zhiwei Feng
Journal:  ACS Chem Neurosci       Date:  2019-07-15       Impact factor: 4.418

Review 2.  Noradrenergic Mechanisms in Fentanyl-Mediated Rapid Death Explain Failure of Naloxone in the Opioid Crisis.

Authors:  Randy Torralva; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2019-09-06       Impact factor: 4.030

3.  Dexmedetomidine and fentanyl exhibit temperature dependent effects on human respiratory cilia.

Authors:  Nils Welchering; Sebastian Ochoa; Xin Tian; Richard Francis; Maliha Zahid; Ricardo Muñoz; Cecilia W Lo
Journal:  Front Pediatr       Date:  2015-02-11       Impact factor: 3.418

4.  Patterns of drug prescriptions in an orthogeriatric ward as compared to orthopaedic ward: results from the Trondheim Hip Fracture Trial-a randomised clinical trial.

Authors:  Marianne Heltne; Ingvild Saltvedt; Stian Lydersen; Anders Prestmo; Olav Sletvold; Olav Spigset
Journal:  Eur J Clin Pharmacol       Date:  2017-05-26       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.